| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NANOSTRING TECHNOLOGIES INC | 3,959,440 | 79,110,000 | 48.62% | ||
| 2 | Oxford Immunotec Global PLC | 2,153,092 | 27,043,000 | 16.62% | ||
| 3 | SIENTRA INC | 2,730,765 | 24,550,000 | 15.09% | ||
| 4 | Catabasis Pharmaceuticals Inc | 2,752,488 | 16,955,000 | 10.42% | ||
| 5 | VBI VACCINES INC COM NEW | 2,691,042 | 9,230,000 | 5.67% | ||
| 6 | ESSA Pharma | 2,121,212 | 5,833,000 | 3.58% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001431431-16-000004, filed 2016.11.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
